AstraZeneca PLC (AZN)
-NYSE 51.56 May 17, 4:00PM EDT|Pre-Market
:
51.44 
0.14 (0.27%) 9:10AM EDT - Nasdaq Real Time Price
| Prev Close: | 51.56 |
|---|
| Open: | N/A |
|---|
| Bid: | 51.39 x 400 |
|---|
| Ask: | 51.41 x 200 |
|---|
| 1y Target Est: | 47.58 |
|---|
| Beta: | 0.55 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 39.72 - 52.27 |
|---|
| Volume: | 200 |
|---|
| Avg Vol (3m): | 2,009,960 |
|---|
| Market Cap: | 64.45B |
|---|
| P/E (ttm): | 11.40 |
|---|
| EPS (ttm): | 4.52 |
|---|
| Div & Yield: | 3.80 (7.40%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Statin Users May Have a Reason to Rejoice After This Dataat Motley Fool(Sun, May 19)
- Pick Your Poison: Overweight or High Cholesterolat Motley Fool(Sun, May 19)
- 1 Giant Leap for MannKindat Motley Fool(Sat, May 18)
- 3 Healthcare Stocks Stories To Close Out the Trading Weekat Wall St. Cheat Sheet(Fri, May 17)
- Impax Labs launches generic version of ZomigAP(Fri, May 17)
- Impax commenced shipment of authorized generic Zomigtheflyonthewall.com(Fri, May 17)
- Good News for Roche's TarcevaZacks(Thu, May 16)
- Cheerleaders: Look Beyond Pharma For JobsYCharts(Thu, May 16)
- Is AstraZeneca Gearing Up for a Shopping Spree?at Motley Fool(Wed, May 15)
- Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stockat Seeking Alpha(Wed, May 15)
- A Closer Look at AstraZeneca's Dividend Potentialat Motley Fool(Tue, May 14)
- What To Buy And Sell In Your High-Yield Portfolioat Seeking Alpha(Tue, May 14)
- Big Pharma's Biggest Losersat Motley Fool(Tue, May 14)
- Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg saystheflyonthewall.com(Mon, May 13)
- Assessing Your Asthma is Key to Taking ControlPR Newswire(Mon, May 13)
Key Statistics
| Forward P/E (1 yr): | 9.99 |
|---|
| P/S (ttm): | 2.39 |
|---|
| Ex-Dividend Date: | 13-Feb-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.34 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.19 |
|---|
| Mean Recommendation*: | 3.4 |
|---|
| PEG Ratio (5 yr expected): | -1.02 |
|---|
Business Summary
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide.
View More